| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.86B | 6.79B | 6.25B | 19.14B | 16.39B | 13.90B |
| Gross Profit | 17.82B | 6.79B | 6.25B | 6.56B | 6.89B | 5.18B |
| EBITDA | 2.53B | 20.52B | 18.58B | 14.76B | 8.58B | 6.49B |
| Net Income | 3.67B | 3.71B | 3.52B | 5.18B | 4.71B | 3.02B |
Balance Sheet | ||||||
| Total Assets | 485.51B | 445.22B | 403.40B | 389.41B | 399.18B | 245.65B |
| Cash, Cash Equivalents and Short-Term Investments | 95.21B | 88.04B | 83.90B | 87.79B | 103.57B | 40.17B |
| Total Debt | 171.19B | 330.19B | 269.21B | 141.79B | 140.47B | 85.47B |
| Total Liabilities | 450.22B | 409.43B | 369.41B | 355.31B | 370.37B | 223.30B |
| Stockholders Equity | 34.65B | 35.36B | 33.48B | 33.16B | 28.56B | 22.05B |
Cash Flow | ||||||
| Free Cash Flow | -7.39B | 5.27B | -6.05B | -12.20B | 9.57B | -2.40B |
| Operating Cash Flow | -6.69B | 6.33B | -4.09B | -11.38B | 10.55B | -1.64B |
| Investing Cash Flow | -33.21B | -2.34B | -3.88B | -1.23B | -31.13B | -11.13B |
| Financing Cash Flow | 41.67B | -1.94B | -2.99B | 450.00M | 72.19B | 20.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $32.22B | 29.11 | 19.88% | 0.46% | 11.88% | 28.96% | |
74 Outperform | $169.44B | 20.00 | 17.91% | 1.07% | 5.90% | 66.60% | |
70 Outperform | $29.13B | 14.06 | 16.94% | 1.26% | 6.45% | 5.85% | |
69 Neutral | $279.50B | 16.54 | 15.45% | 2.14% | 7.22% | 48.18% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $268.78B | 16.00 | 13.81% | 1.55% | 2.31% | 44.49% | |
63 Neutral | $57.64B | 12.90 | 10.75% | 3.06% | 1.24% | -0.75% |